Novel motif:59
From FANTOM5_SSTAR
name: | motif59_NCWCCARNR |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0032526 | response to retinoic acid | 2.609589e-15 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 5.346251e-15 |
GO:0035814 | negative regulation of renal sodium excretion | 1.223747e-14 |
GO:0071300 | cellular response to retinoic acid | 1.870068e-14 |
GO:0034505 | tooth mineralization | 3.854085e-14 |
GO:0071299 | cellular response to vitamin A | 4.820250e-13 |
GO:0060346 | bone trabecula formation | 7.098297e-13 |
GO:0002149 | hypochlorous acid biosynthetic process | 7.228875e-13 |
GO:0044130 | negative regulation of growth of symbiont in host | 1.436921e-12 |
GO:0031670 | cellular response to nutrient | 2.533134e-12 |
GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin | 4.118366e-12 |
GO:0048873 | homeostasis of number of cells within a tissue | 4.441792e-12 |
GO:0010718 | positive regulation of epithelial to mesenchymal transition | 1.002205e-11 |
GO:0010717 | regulation of epithelial to mesenchymal transition | 1.236815e-11 |
GO:0043903 | regulation of symbiosis, encompassing mutualism through parasitism | 1.337875e-11 |
GO:0006959 | humoral immune response | 1.437259e-11 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 1.547443e-11 |
GO:0006927 | transformed cell apoptosis | 2.485054e-11 |
GO:0010770 | positive regulation of cell morphogenesis involved in differentiation | 2.588332e-11 |
GO:0060124 | positive regulation of growth hormone secretion | 5.148628e-11 |
GO:0002679 | respiratory burst involved in defense response | 6.885544e-11 |
GO:0001957 | intramembranous ossification | 1.620324e-10 |
GO:0033209 | tumor necrosis factor-mediated signaling pathway | 2.538095e-10 |
GO:0044062 | regulation of excretion | 5.984364e-10 |
GO:0033189 | response to vitamin A | 6.277611e-10 |
GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin | 6.478758e-10 |
GO:0060343 | trabecula formation | 8.190565e-10 |
GO:0035691 | macrophage migration inhibitory factor signaling pathway | 1.047739e-9 |
GO:0042542 | response to hydrogen peroxide | 1.058984e-9 |
GO:0071295 | cellular response to vitamin | 1.129172e-9 |
GO:0007586 | digestion | 1.395049e-9 |
GO:0061383 | trabecula morphogenesis | 1.556585e-9 |
GO:0006768 | biotin metabolic process | 1.780476e-9 |
GO:0008078 | mesodermal cell migration | 1.786232e-9 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 2.626533e-9 |
GO:0019884 | antigen processing and presentation of exogenous antigen | 3.965260e-9 |
GO:0019276 | UDP-N-acetylgalactosamine metabolic process | 4.491654e-9 |
GO:0051956 | negative regulation of amino acid transport | 4.835694e-9 |
GO:0007162 | negative regulation of cell adhesion | 6.043908e-9 |
GO:0042488 | positive regulation of odontogenesis of dentine-containing tooth | 7.013274e-9 |
GO:0019883 | antigen processing and presentation of endogenous antigen | 7.430104e-9 |
GO:0051488 | activation of anaphase-promoting complex activity | 8.623501e-9 |
GO:0002443 | leukocyte mediated immunity | 1.064061e-8 |
GO:0030198 | extracellular matrix organization | 1.347263e-8 |
GO:0000302 | response to reactive oxygen species | 1.444244e-8 |
GO:0030277 | maintenance of gastrointestinal epithelium | 1.450506e-8 |
GO:0002037 | negative regulation of L-glutamate transport | 1.495525e-8 |
GO:0045994 | positive regulation of translational initiation by iron | 1.495525e-8 |
GO:0002920 | regulation of humoral immune response | 1.556507e-8 |
GO:0035813 | regulation of renal sodium excretion | 1.564148e-8 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 1.616259e-8 |
GO:0000389 | nuclear mRNA 3'-splice site recognition | 1.661723e-8 |
GO:0006447 | regulation of translational initiation by iron | 1.723149e-8 |
GO:0002449 | lymphocyte mediated immunity | 1.781039e-8 |
GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 1.927149e-8 |
GO:0031536 | positive regulation of exit from mitosis | 1.944321e-8 |
GO:0046730 | induction of host immune response by virus | 1.944321e-8 |
GO:0060611 | mammary gland fat development | 2.049597e-8 |
GO:0033273 | response to vitamin | 2.066963e-8 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 2.320263e-8 |
GO:0035854 | eosinophil fate commitment | 2.330988e-8 |
GO:0030222 | eosinophil differentiation | 2.330988e-8 |
GO:0060444 | branching involved in mammary gland duct morphogenesis | 2.484385e-8 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 2.580480e-8 |
GO:0043901 | negative regulation of multi-organism process | 3.110329e-8 |
GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter | 3.155531e-8 |
GO:0019724 | B cell mediated immunity | 3.201054e-8 |
GO:0002830 | positive regulation of type 2 immune response | 5.526638e-8 |
GO:0002718 | regulation of cytokine production involved in immune response | 5.584966e-8 |
GO:0016064 | immunoglobulin mediated immune response | 6.795909e-8 |
GO:0030851 | granulocyte differentiation | 7.026701e-8 |
GO:0050832 | defense response to fungus | 7.619502e-8 |
GO:0021879 | forebrain neuron differentiation | 7.680328e-8 |
GO:0042696 | menarche | 7.842984e-8 |
GO:0045630 | positive regulation of T-helper 2 cell differentiation | 8.176929e-8 |
GO:0001894 | tissue homeostasis | 8.429143e-8 |
GO:0051241 | negative regulation of multicellular organismal process | 8.522587e-8 |
GO:0043586 | tongue development | 9.527007e-8 |
GO:0048708 | astrocyte differentiation | 1.065080e-7 |
GO:0060014 | granulosa cell differentiation | 1.068782e-7 |
GO:0046732 | active induction of host immune response by virus | 1.512719e-7 |
GO:0070208 | protein heterotrimerization | 1.602406e-7 |
GO:0002712 | regulation of B cell mediated immunity | 1.756723e-7 |
GO:0009651 | response to salt stress | 1.817048e-7 |
GO:0022408 | negative regulation of cell-cell adhesion | 1.853715e-7 |
GO:0032964 | collagen biosynthetic process | 1.890279e-7 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.894937e-7 |
GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep | 2.121848e-7 |
GO:0048872 | homeostasis of number of cells | 2.210755e-7 |
GO:0042503 | tyrosine phosphorylation of Stat3 protein | 2.364867e-7 |
GO:0045651 | positive regulation of macrophage differentiation | 2.391137e-7 |
GO:0002074 | extraocular skeletal muscle development | 2.913232e-7 |
GO:0032689 | negative regulation of interferon-gamma production | 3.078333e-7 |
GO:0002016 | regulation of blood volume by renin-angiotensin | 3.102576e-7 |
GO:0030206 | chondroitin sulfate biosynthetic process | 3.190404e-7 |
GO:0002889 | regulation of immunoglobulin mediated immune response | 3.282231e-7 |
GO:0030852 | regulation of granulocyte differentiation | 3.735557e-7 |
GO:0042506 | tyrosine phosphorylation of Stat5 protein | 3.833596e-7 |
GO:0043542 | endothelial cell migration | 3.864763e-7 |
GO:0032673 | regulation of interleukin-4 production | 3.969889e-7 |
GO:0045059 | positive thymic T cell selection | 4.050751e-7 |
GO:0003073 | regulation of systemic arterial blood pressure | 4.385521e-7 |
GO:0043206 | fibril organization | 4.688651e-7 |
GO:0061048 | negative regulation of branching involved in lung morphogenesis | 4.909427e-7 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 4.909427e-7 |
GO:0002678 | positive regulation of chronic inflammatory response | 5.023695e-7 |
GO:0045649 | regulation of macrophage differentiation | 5.031282e-7 |
GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 5.162423e-7 |
GO:0007617 | mating behavior | 5.550256e-7 |
GO:0071356 | cellular response to tumor necrosis factor | 5.628010e-7 |
GO:0045835 | negative regulation of meiosis | 5.893357e-7 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 7.352627e-7 |
GO:0031297 | replication fork processing | 8.524718e-7 |
GO:0007509 | mesoderm migration involved in gastrulation | 8.875092e-7 |
GO:0001990 | regulation of systemic arterial blood pressure by hormone | 9.958984e-7 |
GO:0030826 | regulation of cGMP biosynthetic process | 1.008267e-6 |
GO:0032753 | positive regulation of interleukin-4 production | 1.009744e-6 |
GO:0006958 | complement activation, classical pathway | 1.037154e-6 |
GO:0009605 | response to external stimulus | 1.050420e-6 |
GO:0003417 | growth plate cartilage development | 1.134058e-6 |
GO:2000021 | regulation of ion homeostasis | 1.198773e-6 |
GO:0006956 | complement activation | 1.236583e-6 |
GO:0002828 | regulation of type 2 immune response | 1.356987e-6 |
GO:0003044 | regulation of systemic arterial blood pressure mediated by a chemical signal | 1.368759e-6 |
GO:0002339 | B cell selection | 1.545229e-6 |
GO:0051533 | positive regulation of NFAT protein import into nucleus | 1.594645e-6 |
GO:0048341 | paraxial mesoderm formation | 1.659375e-6 |
GO:0007589 | body fluid secretion | 1.690020e-6 |
GO:0010984 | regulation of lipoprotein particle clearance | 1.789818e-6 |
GO:0042074 | cell migration involved in gastrulation | 1.909590e-6 |
GO:0002761 | regulation of myeloid leukocyte differentiation | 1.974287e-6 |
GO:0051798 | positive regulation of hair follicle development | 2.119515e-6 |
GO:0030037 | actin filament reorganization involved in cell cycle | 2.170790e-6 |
GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | 2.171818e-6 |
GO:0042363 | fat-soluble vitamin catabolic process | 2.218189e-6 |
GO:0060419 | heart growth | 2.322177e-6 |
GO:0002906 | negative regulation of mature B cell apoptosis | 2.479643e-6 |
GO:0050868 | negative regulation of T cell activation | 2.481795e-6 |
GO:0021872 | forebrain generation of neurons | 2.502332e-6 |
GO:0045005 | maintenance of fidelity involved in DNA-dependent DNA replication | 2.505939e-6 |
GO:0048771 | tissue remodeling | 2.548089e-6 |
GO:0051291 | protein heterooligomerization | 2.838356e-6 |
GO:0002579 | positive regulation of antigen processing and presentation | 2.905937e-6 |
GO:0070670 | response to interleukin-4 | 3.178365e-6 |
GO:0010669 | epithelial structure maintenance | 3.186539e-6 |
GO:0060160 | negative regulation of dopamine receptor signaling pathway | 3.562995e-6 |
GO:0002252 | immune effector process | 3.567038e-6 |
GO:0048145 | regulation of fibroblast proliferation | 3.701148e-6 |
GO:0070345 | negative regulation of fat cell proliferation | 3.741989e-6 |
GO:0003009 | skeletal muscle contraction | 3.742802e-6 |
GO:0043029 | T cell homeostasis | 3.958685e-6 |
GO:0055017 | cardiac muscle tissue growth | 4.116340e-6 |
GO:0021542 | dentate gyrus development | 4.182604e-6 |
GO:0042744 | hydrogen peroxide catabolic process | 4.371286e-6 |
GO:0045123 | cellular extravasation | 4.418579e-6 |
GO:0002250 | adaptive immune response | 4.526726e-6 |
GO:0045581 | negative regulation of T cell differentiation | 4.537790e-6 |
GO:0002344 | B cell affinity maturation | 4.654120e-6 |
GO:0055070 | copper ion homeostasis | 5.012529e-6 |
GO:0002861 | regulation of inflammatory response to antigenic stimulus | 5.022457e-6 |
GO:0006551 | leucine metabolic process | 5.072583e-6 |
GO:0045684 | positive regulation of epidermis development | 5.298095e-6 |
GO:0006878 | cellular copper ion homeostasis | 5.371022e-6 |
GO:0032862 | activation of Rho GTPase activity | 5.529163e-6 |
GO:0045112 | integrin biosynthetic process | 5.753790e-6 |
GO:0045061 | thymic T cell selection | 5.783928e-6 |
GO:0010994 | free ubiquitin chain polymerization | 6.151561e-6 |
GO:0045580 | regulation of T cell differentiation | 6.223682e-6 |
GO:0042703 | menstruation | 6.229503e-6 |
GO:0019101 | female somatic sex determination | 6.229503e-6 |
GO:0060350 | endochondral bone morphogenesis | 6.537810e-6 |
GO:0060430 | lung saccule development | 6.640578e-6 |
GO:0008217 | regulation of blood pressure | 6.785898e-6 |
GO:0002922 | positive regulation of humoral immune response | 6.852085e-6 |
GO:0032736 | positive regulation of interleukin-13 production | 7.028991e-6 |
GO:0003416 | endochondral bone growth | 7.047226e-6 |
GO:0006884 | cell volume homeostasis | 7.356015e-6 |
GO:0060123 | regulation of growth hormone secretion | 7.379186e-6 |
GO:0007584 | response to nutrient | 8.051744e-6 |
GO:0019098 | reproductive behavior | 8.137688e-6 |
GO:0021759 | globus pallidus development | 9.353015e-6 |
GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 9.448842e-6 |
GO:0032863 | activation of Rac GTPase activity | 9.448842e-6 |
GO:0002891 | positive regulation of immunoglobulin mediated immune response | 9.987423e-6 |
GO:0051788 | response to misfolded protein | 1.011996e-5 |
GO:0048730 | epidermis morphogenesis | 1.090888e-5 |
GO:0048298 | positive regulation of isotype switching to IgA isotypes | 1.145613e-5 |
GO:0051955 | regulation of amino acid transport | 1.163948e-5 |
GO:0035572 | N-terminal peptidyl-serine dimethylation | 1.243425e-5 |
GO:0035573 | N-terminal peptidyl-serine trimethylation | 1.243425e-5 |
GO:0018016 | N-terminal peptidyl-proline dimethylation | 1.243425e-5 |
GO:0018012 | N-terminal peptidyl-alanine trimethylation | 1.243425e-5 |
GO:0050909 | sensory perception of taste | 1.256389e-5 |
GO:0032720 | negative regulation of tumor necrosis factor production | 1.284800e-5 |
GO:0042476 | odontogenesis | 1.298945e-5 |
GO:0009817 | defense response to fungus, incompatible interaction | 1.310333e-5 |
GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 1.310333e-5 |
GO:0030952 | establishment or maintenance of cytoskeleton polarity | 1.372211e-5 |
GO:0002700 | regulation of production of molecular mediator of immune response | 1.470539e-5 |
GO:0001878 | response to yeast | 1.531811e-5 |
GO:0090218 | positive regulation of lipid kinase activity | 1.534073e-5 |
GO:0031667 | response to nutrient levels | 1.540759e-5 |
GO:0030322 | stabilization of membrane potential | 1.666922e-5 |
GO:0071316 | cellular response to nicotine | 1.682374e-5 |
GO:0034616 | response to laminar fluid shear stress | 1.685676e-5 |
GO:0050902 | leukocyte adhesive activation | 1.725556e-5 |
GO:0051041 | positive regulation of calcium-independent cell-cell adhesion | 1.725556e-5 |
GO:0002019 | regulation of renal output by angiotensin | 1.725556e-5 |
GO:0015760 | glucose-6-phosphate transport | 1.728892e-5 |
GO:0060557 | positive regulation of vitamin D biosynthetic process | 1.817517e-5 |
GO:2000107 | negative regulation of leukocyte apoptosis | 1.886590e-5 |
GO:0045619 | regulation of lymphocyte differentiation | 1.896663e-5 |
GO:0048384 | retinoic acid receptor signaling pathway | 2.025206e-5 |
GO:0046543 | development of secondary female sexual characteristics | 2.133216e-5 |
GO:0042482 | positive regulation of odontogenesis | 2.157545e-5 |
GO:0002921 | negative regulation of humoral immune response | 2.157545e-5 |
GO:0060251 | regulation of glial cell proliferation | 2.348587e-5 |
GO:0009235 | cobalamin metabolic process | 2.414603e-5 |
GO:0085018 | maintenance of symbiont-containing vacuole via substance secreted by host | 2.500105e-5 |
GO:0035378 | carbon dioxide transmembrane transport | 2.500105e-5 |
GO:0035377 | transepithelial water transport | 2.500105e-5 |
GO:0030950 | establishment or maintenance of actin cytoskeleton polarity | 2.500105e-5 |
GO:0035265 | organ growth | 2.581099e-5 |
GO:0002026 | regulation of the force of heart contraction | 2.637847e-5 |
GO:0045060 | negative thymic T cell selection | 2.648785e-5 |
GO:0045338 | farnesyl diphosphate metabolic process | 2.677141e-5 |
GO:0001974 | blood vessel remodeling | 2.741943e-5 |
GO:0051591 | response to cAMP | 2.874847e-5 |
GO:0045109 | intermediate filament organization | 3.051853e-5 |
GO:0042487 | regulation of odontogenesis of dentine-containing tooth | 3.053429e-5 |
GO:0022010 | central nervous system myelination | 3.198713e-5 |
GO:0071529 | cementum mineralization | 3.281612e-5 |
GO:0071803 | positive regulation of podosome assembly | 3.436371e-5 |
GO:0071071 | regulation of phospholipid biosynthetic process | 3.485846e-5 |
GO:0009303 | rRNA transcription | 3.513883e-5 |
GO:0061153 | trachea gland development | 3.527514e-5 |
GO:0002903 | negative regulation of B cell apoptosis | 3.815632e-5 |
GO:0042743 | hydrogen peroxide metabolic process | 3.838603e-5 |
GO:0007635 | chemosensory behavior | 3.899212e-5 |
GO:0071732 | cellular response to nitric oxide | 4.008251e-5 |
GO:0090361 | regulation of platelet-derived growth factor production | 4.454115e-5 |
GO:0007009 | plasma membrane organization | 4.532080e-5 |
GO:0045655 | regulation of monocyte differentiation | 4.537075e-5 |
GO:0021877 | forebrain neuron fate commitment | 4.807267e-5 |
GO:0042391 | regulation of membrane potential | 4.918027e-5 |
GO:0006066 | alcohol metabolic process | 4.939929e-5 |
GO:0060349 | bone morphogenesis | 5.052690e-5 |
GO:0010719 | negative regulation of epithelial to mesenchymal transition | 5.105034e-5 |
GO:0002676 | regulation of chronic inflammatory response | 5.329121e-5 |
GO:0009225 | nucleotide-sugar metabolic process | 5.337330e-5 |
GO:0040018 | positive regulation of multicellular organism growth | 5.410312e-5 |
GO:0010388 | cullin deneddylation | 5.763739e-5 |
GO:0071072 | negative regulation of phospholipid biosynthetic process | 5.920106e-5 |
GO:0008544 | epidermis development | 5.925392e-5 |
GO:0031282 | regulation of guanylate cyclase activity | 6.121205e-5 |
GO:0002036 | regulation of L-glutamate transport | 6.159115e-5 |
GO:0044070 | regulation of anion transport | 6.170501e-5 |
GO:0035048 | splicing factor protein import into nucleus | 6.233200e-5 |
GO:0034653 | retinoic acid catabolic process | 6.270737e-5 |
GO:0045657 | positive regulation of monocyte differentiation | 6.287806e-5 |
GO:0043526 | neuroprotection | 6.358398e-5 |
GO:0017148 | negative regulation of translation | 6.371567e-5 |
GO:0046325 | negative regulation of glucose import | 6.534340e-5 |
GO:0035419 | activation of MAPK activity involved in innate immune response | 6.535223e-5 |
GO:0022600 | digestive system process | 6.655298e-5 |
GO:0060133 | somatotropin secreting cell development | 7.108128e-5 |
GO:0014002 | astrocyte development | 7.327179e-5 |
GO:0002902 | regulation of B cell apoptosis | 7.327179e-5 |
GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis | 7.610561e-5 |
GO:0045637 | regulation of myeloid cell differentiation | 7.821407e-5 |
GO:0022601 | menstrual cycle phase | 7.835253e-5 |
GO:0051156 | glucose 6-phosphate metabolic process | 7.939340e-5 |
GO:0009416 | response to light stimulus | 8.011392e-5 |
GO:0014806 | smooth muscle hyperplasia | 8.201661e-5 |
GO:0055069 | zinc ion homeostasis | 8.546468e-5 |
GO:0002522 | leukocyte migration involved in immune response | 8.555470e-5 |
GO:0006244 | pyrimidine nucleotide catabolic process | 8.572848e-5 |
GO:0045662 | negative regulation of myoblast differentiation | 8.818988e-5 |
GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure | 8.847886e-5 |
GO:0046339 | diacylglycerol metabolic process | 9.333803e-5 |
GO:0000712 | resolution of meiotic recombination intermediates | 9.415356e-5 |
GO:0008065 | establishment of blood-nerve barrier | 9.523703e-5 |
GO:0010624 | regulation of Schwann cell proliferation | 9.542619e-5 |
GO:0045414 | regulation of interleukin-8 biosynthetic process | 1.002213e-4 |
GO:0044154 | histone H3-K14 acetylation | 1.019256e-4 |
GO:0002573 | myeloid leukocyte differentiation | 1.019681e-4 |
GO:0051148 | negative regulation of muscle cell differentiation | 1.025750e-4 |
GO:0043368 | positive T cell selection | 1.036631e-4 |
GO:0002209 | behavioral defense response | 1.051562e-4 |
GO:0042538 | hyperosmotic salinity response | 1.071912e-4 |
GO:0048469 | cell maturation | 1.082103e-4 |
GO:0051270 | regulation of cellular component movement | 1.109662e-4 |
GO:0072109 | glomerular mesangium development | 1.111419e-4 |
GO:0021984 | adenohypophysis development | 1.128678e-4 |
GO:0033081 | regulation of T cell differentiation in thymus | 1.131996e-4 |
GO:0001818 | negative regulation of cytokine production | 1.146134e-4 |
GO:0010511 | regulation of phosphatidylinositol biosynthetic process | 1.151716e-4 |
GO:0048382 | mesendoderm development | 1.153524e-4 |
GO:0048340 | paraxial mesoderm morphogenesis | 1.178437e-4 |
GO:0033327 | Leydig cell differentiation | 1.196730e-4 |
GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter | 1.206337e-4 |
GO:0009191 | ribonucleoside diphosphate catabolic process | 1.206337e-4 |
GO:0006285 | base-excision repair, AP site formation | 1.206337e-4 |
GO:0009298 | GDP-mannose biosynthetic process | 1.219245e-4 |
GO:0001826 | inner cell mass cell differentiation | 1.219245e-4 |
GO:0060396 | growth hormone receptor signaling pathway | 1.239627e-4 |
GO:0045556 | positive regulation of TRAIL biosynthetic process | 1.240171e-4 |
GO:0046032 | ADP catabolic process | 1.248117e-4 |
GO:0046709 | IDP catabolic process | 1.248117e-4 |
GO:0010771 | negative regulation of cell morphogenesis involved in differentiation | 1.248970e-4 |
GO:0060591 | chondroblast differentiation | 1.253973e-4 |
GO:0006829 | zinc ion transport | 1.273411e-4 |
GO:0043627 | response to estrogen stimulus | 1.274987e-4 |
GO:0043585 | nose morphogenesis | 1.292882e-4 |
GO:0032754 | positive regulation of interleukin-5 production | 1.379737e-4 |
GO:0045638 | negative regulation of myeloid cell differentiation | 1.386102e-4 |
GO:0022407 | regulation of cell-cell adhesion | 1.386106e-4 |
GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process | 1.394412e-4 |
GO:0002863 | positive regulation of inflammatory response to antigenic stimulus | 1.394412e-4 |
GO:0060038 | cardiac muscle cell proliferation | 1.399283e-4 |
GO:0016264 | gap junction assembly | 1.399547e-4 |
GO:0001649 | osteoblast differentiation | 1.404590e-4 |
GO:0035307 | positive regulation of protein dephosphorylation | 1.423738e-4 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1.466287e-4 |
GO:0060456 | positive regulation of digestive system process | 1.527283e-4 |
GO:0010742 | macrophage derived foam cell differentiation | 1.527283e-4 |
GO:0039020 | pronephric nephron tubule development | 1.540437e-4 |
GO:0035565 | regulation of pronephros size | 1.540437e-4 |
GO:0045948 | positive regulation of translational initiation | 1.541998e-4 |
GO:0051272 | positive regulation of cellular component movement | 1.558429e-4 |
GO:0001662 | behavioral fear response | 1.601519e-4 |
GO:0008643 | carbohydrate transport | 1.622137e-4 |
GO:0002513 | tolerance induction to self antigen | 1.655073e-4 |
GO:0045471 | response to ethanol | 1.671652e-4 |
GO:0060763 | mammary duct terminal end bud growth | 1.675974e-4 |
GO:0022614 | membrane to membrane docking | 1.676393e-4 |
GO:0051438 | regulation of ubiquitin-protein ligase activity | 1.687355e-4 |
GO:0009264 | deoxyribonucleotide catabolic process | 1.699075e-4 |
GO:0050863 | regulation of T cell activation | 1.701456e-4 |
GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 1.705850e-4 |
GO:0034405 | response to fluid shear stress | 1.724494e-4 |
GO:0045136 | development of secondary sexual characteristics | 1.749857e-4 |
GO:0060751 | branch elongation involved in mammary gland duct branching | 1.803998e-4 |
GO:0052565 | response to defense-related host nitric oxide production | 1.824686e-4 |
GO:0030334 | regulation of cell migration | 1.831630e-4 |
GO:0001906 | cell killing | 1.832977e-4 |
GO:0051764 | actin crosslink formation | 1.838956e-4 |
GO:0033002 | muscle cell proliferation | 1.873568e-4 |
GO:0060693 | regulation of branching involved in salivary gland morphogenesis | 1.895043e-4 |
GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 1.895043e-4 |
GO:0018350 | protein esterification | 1.901639e-4 |
GO:0044258 | intestinal lipid catabolic process | 1.901639e-4 |
GO:0042093 | T-helper cell differentiation | 1.914389e-4 |
GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process | 1.936375e-4 |
GO:0035313 | wound healing, spreading of epidermal cells | 1.949584e-4 |
GO:0043266 | regulation of potassium ion transport | 1.962860e-4 |
GO:0042508 | tyrosine phosphorylation of Stat1 protein | 1.963122e-4 |
GO:0009620 | response to fungus | 1.980010e-4 |
GO:0045582 | positive regulation of T cell differentiation | 2.001557e-4 |
GO:0010812 | negative regulation of cell-substrate adhesion | 2.032509e-4 |
GO:0044281 | small molecule metabolic process | 2.052862e-4 |
GO:0071577 | zinc ion transmembrane transport | 2.074160e-4 |
GO:0032321 | positive regulation of Rho GTPase activity | 2.102518e-4 |
GO:0003100 | regulation of systemic arterial blood pressure by endothelin | 2.148764e-4 |
GO:0071474 | cellular hyperosmotic response | 2.176223e-4 |
GO:0033239 | negative regulation of cellular amine metabolic process | 2.176223e-4 |
GO:0032780 | negative regulation of ATPase activity | 2.213252e-4 |
GO:0009226 | nucleotide-sugar biosynthetic process | 2.213252e-4 |
GO:0060603 | mammary gland duct morphogenesis | 2.222504e-4 |
GO:0045475 | locomotor rhythm | 2.231862e-4 |
GO:0021528 | commissural neuron differentiation in spinal cord | 2.231862e-4 |
GO:0032425 | positive regulation of mismatch repair | 2.252735e-4 |
GO:0006515 | misfolded or incompletely synthesized protein catabolic process | 2.278215e-4 |
GO:0021548 | pons development | 2.300946e-4 |
GO:0043551 | regulation of phosphatidylinositol 3-kinase activity | 2.353226e-4 |
GO:0060179 | male mating behavior | 2.360478e-4 |
GO:0021754 | facial nucleus development | 2.390386e-4 |
GO:0003058 | hormonal regulation of the force of heart contraction | 2.390386e-4 |
GO:0032900 | negative regulation of neurotrophin production | 2.399979e-4 |
GO:0032244 | positive regulation of nucleoside transport | 2.399979e-4 |
GO:0043932 | ossification involved in bone remodeling | 2.427598e-4 |
GO:0007159 | leukocyte cell-cell adhesion | 2.508577e-4 |
GO:0051017 | actin filament bundle assembly | 2.547389e-4 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 2.612746e-4 |
GO:0045838 | positive regulation of membrane potential | 2.717559e-4 |
GO:0048320 | axial mesoderm formation | 2.771342e-4 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 2.818035e-4 |
GO:0022604 | regulation of cell morphogenesis | 2.826339e-4 |
GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin | 2.837806e-4 |
GO:0050862 | positive regulation of T cell receptor signaling pathway | 2.841068e-4 |
GO:0034224 | cellular response to zinc ion starvation | 2.884381e-4 |
GO:0061088 | regulation of sequestering of zinc ion | 2.919255e-4 |
GO:0010935 | regulation of macrophage cytokine production | 3.046600e-4 |
GO:0009991 | response to extracellular stimulus | 3.047145e-4 |
GO:0043587 | tongue morphogenesis | 3.059850e-4 |
GO:0030237 | female sex determination | 3.153617e-4 |
GO:0016056 | rhodopsin mediated signaling pathway | 3.153617e-4 |
GO:0043647 | inositol phosphate metabolic process | 3.165663e-4 |
GO:0046849 | bone remodeling | 3.208574e-4 |
GO:0042501 | serine phosphorylation of STAT protein | 3.264889e-4 |
GO:0032963 | collagen metabolic process | 3.314746e-4 |
GO:0060087 | relaxation of vascular smooth muscle | 3.350303e-4 |
GO:0051016 | barbed-end actin filament capping | 3.353100e-4 |
GO:0030520 | estrogen receptor signaling pathway | 3.414158e-4 |
GO:0007512 | adult heart development | 3.444114e-4 |
GO:0032656 | regulation of interleukin-13 production | 3.473049e-4 |
GO:0002682 | regulation of immune system process | 3.474584e-4 |
GO:0021612 | facial nerve structural organization | 3.488735e-4 |
GO:0035306 | positive regulation of dephosphorylation | 3.503287e-4 |
GO:0030853 | negative regulation of granulocyte differentiation | 3.535148e-4 |
GO:0006414 | translational elongation | 3.574302e-4 |
GO:2000145 | regulation of cell motility | 3.594016e-4 |
GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I | 3.740358e-4 |
GO:0010536 | positive regulation of activation of Janus kinase activity | 3.740358e-4 |
GO:0060078 | regulation of postsynaptic membrane potential | 3.780914e-4 |
GO:0032674 | regulation of interleukin-5 production | 3.793510e-4 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 3.844336e-4 |
GO:0051048 | negative regulation of secretion | 4.037834e-4 |
GO:0035967 | cellular response to topologically incorrect protein | 4.060345e-4 |
GO:0006955 | immune response | 4.065868e-4 |
GO:0051023 | regulation of immunoglobulin secretion | 4.075660e-4 |
GO:0015817 | histidine transport | 4.110647e-4 |
GO:0043268 | positive regulation of potassium ion transport | 4.142076e-4 |
GO:0018293 | protein-FAD linkage | 4.193494e-4 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 4.193494e-4 |
GO:0043588 | skin development | 4.221401e-4 |
GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 4.223620e-4 |
GO:2000147 | positive regulation of cell motility | 4.319623e-4 |
GO:0070228 | regulation of lymphocyte apoptosis | 4.359300e-4 |
GO:0051444 | negative regulation of ubiquitin-protein ligase activity | 4.363756e-4 |
GO:0018993 | somatic sex determination | 4.393564e-4 |
GO:0042088 | T-helper 1 type immune response | 4.453488e-4 |
GO:0014909 | smooth muscle cell migration | 4.477506e-4 |
GO:0061370 | testosterone biosynthetic process | 4.545160e-4 |
GO:0050756 | fractalkine metabolic process | 4.545160e-4 |
GO:0033595 | response to genistein | 4.545160e-4 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 4.548542e-4 |
GO:0072262 | metanephric glomerular mesangial cell proliferation involved in metanephros development | 4.596977e-4 |
GO:0043128 | positive regulation of 1-phosphatidylinositol 4-kinase activity | 4.596977e-4 |
GO:0007595 | lactation | 4.758115e-4 |
GO:0032355 | response to estradiol stimulus | 4.885704e-4 |
GO:0071899 | negative regulation of estrogen receptor binding | 5.016373e-4 |
GO:0050710 | negative regulation of cytokine secretion | 5.046906e-4 |
GO:0045416 | positive regulation of interleukin-8 biosynthetic process | 5.126278e-4 |
GO:0001909 | leukocyte mediated cytotoxicity | 5.198387e-4 |
GO:0061049 | cell growth involved in cardiac muscle cell development | 5.208906e-4 |
GO:0014873 | response to muscle activity involved in regulation of muscle adaptation | 5.208906e-4 |
GO:0003331 | positive regulation of extracellular matrix constituent secretion | 5.208906e-4 |
GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | 5.208906e-4 |
GO:0046148 | pigment biosynthetic process | 5.271778e-4 |
GO:0046632 | alpha-beta T cell differentiation | 5.337074e-4 |
GO:0043088 | regulation of Cdc42 GTPase activity | 5.371202e-4 |
GO:0048146 | positive regulation of fibroblast proliferation | 5.493104e-4 |
GO:0006754 | ATP biosynthetic process | 5.549256e-4 |
GO:0007096 | regulation of exit from mitosis | 5.632249e-4 |
GO:0034504 | protein localization to nucleus | 5.644698e-4 |
GO:0030335 | positive regulation of cell migration | 5.712868e-4 |
GO:0007260 | tyrosine phosphorylation of STAT protein | 5.715876e-4 |
GO:0010959 | regulation of metal ion transport | 5.731133e-4 |
GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein | 5.768712e-4 |
GO:0019388 | galactose catabolic process | 5.768712e-4 |
GO:0010523 | negative regulation of calcium ion transport into cytosol | 5.802297e-4 |
GO:0045453 | bone resorption | 5.861685e-4 |
GO:0010873 | positive regulation of cholesterol esterification | 5.908042e-4 |
GO:0003099 | positive regulation of the force of heart contraction by chemical signal | 5.921890e-4 |
GO:0048386 | positive regulation of retinoic acid receptor signaling pathway | 6.092886e-4 |
GO:0060708 | spongiotrophoblast differentiation | 6.103237e-4 |
GO:0042592 | homeostatic process | 6.109341e-4 |
GO:0045065 | cytotoxic T cell differentiation | 6.221809e-4 |
GO:0021570 | rhombomere 4 development | 6.221809e-4 |
GO:0048339 | paraxial mesoderm development | 6.228119e-4 |
GO:0048147 | negative regulation of fibroblast proliferation | 6.354005e-4 |
GO:0030099 | myeloid cell differentiation | 6.361495e-4 |
GO:0006855 | drug transmembrane transport | 6.363467e-4 |
GO:0051891 | positive regulation of cardioblast differentiation | 6.512707e-4 |
GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation | 6.540438e-4 |
GO:0045806 | negative regulation of endocytosis | 6.609155e-4 |
GO:0060033 | anatomical structure regression | 6.676972e-4 |
GO:0046415 | urate metabolic process | 6.676972e-4 |
GO:0009181 | purine ribonucleoside diphosphate catabolic process | 6.799806e-4 |
GO:0043400 | cortisol secretion | 6.802939e-4 |
GO:0031669 | cellular response to nutrient levels | 6.804426e-4 |
GO:0051461 | positive regulation of corticotropin secretion | 7.028378e-4 |
GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 7.028378e-4 |
GO:0032696 | negative regulation of interleukin-13 production | 7.216329e-4 |
GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process | 7.370189e-4 |
GO:0072181 | mesonephric duct formation | 7.386028e-4 |
GO:0071733 | transcriptional activation by promoter-enhancer looping | 7.386028e-4 |
GO:0002438 | acute inflammatory response to antigenic stimulus | 7.386028e-4 |
GO:0010724 | regulation of definitive erythrocyte differentiation | 7.386028e-4 |
GO:0051873 | killing by host of symbiont cells | 7.410828e-4 |
GO:0032796 | uropod organization | 7.410828e-4 |
GO:0018963 | phthalate metabolic process | 7.410828e-4 |
GO:0050878 | regulation of body fluid levels | 7.534844e-4 |
GO:0007263 | nitric oxide mediated signal transduction | 7.591426e-4 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 7.678188e-4 |
GO:0060135 | maternal process involved in female pregnancy | 7.681458e-4 |
GO:0048871 | multicellular organismal homeostasis | 7.721096e-4 |
GO:0072376 | protein activation cascade | 7.769375e-4 |
GO:0006552 | leucine catabolic process | 7.774865e-4 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0045940 | positive regulation of steroid metabolic process | 2.735468e-15 |
GO:0001957 | intramembranous ossification | 5.113595e-13 |
GO:0016064 | immunoglobulin mediated immune response | 1.448146e-12 |
GO:0070245 | positive regulation of thymocyte apoptosis | 2.375476e-12 |
GO:0019724 | B cell mediated immunity | 5.100873e-12 |
GO:0002449 | lymphocyte mediated immunity | 9.572203e-12 |
GO:0070234 | positive regulation of T cell apoptosis | 1.513278e-11 |
GO:0010873 | positive regulation of cholesterol esterification | 7.419960e-11 |
GO:0019218 | regulation of steroid metabolic process | 2.633143e-10 |
GO:0010872 | regulation of cholesterol esterification | 2.753603e-10 |
GO:0045834 | positive regulation of lipid metabolic process | 2.762419e-10 |
GO:0070208 | protein heterotrimerization | 3.083388e-10 |
GO:0033700 | phospholipid efflux | 4.016514e-10 |
GO:0044236 | multicellular organismal metabolic process | 4.224710e-10 |
GO:0002579 | positive regulation of antigen processing and presentation | 4.543222e-10 |
GO:0071417 | cellular response to organic nitrogen | 8.389771e-10 |
GO:0002443 | leukocyte mediated immunity | 8.433901e-10 |
GO:0070243 | regulation of thymocyte apoptosis | 8.836210e-10 |
GO:0016126 | sterol biosynthetic process | 2.186411e-9 |
GO:0060346 | bone trabecula formation | 3.261929e-9 |
GO:0071418 | cellular response to amine stimulus | 4.391875e-9 |
GO:0090023 | positive regulation of neutrophil chemotaxis | 5.283163e-9 |
GO:0070228 | regulation of lymphocyte apoptosis | 7.775800e-9 |
GO:0070232 | regulation of T cell apoptosis | 9.882451e-9 |
GO:0070230 | positive regulation of lymphocyte apoptosis | 1.437051e-8 |
GO:0031017 | exocrine pancreas development | 1.571925e-8 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 1.587090e-8 |
GO:0001516 | prostaglandin biosynthetic process | 2.134309e-8 |
GO:0007620 | copulation | 2.332556e-8 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 2.393451e-8 |
GO:0035691 | macrophage migration inhibitory factor signaling pathway | 3.524559e-8 |
GO:0009303 | rRNA transcription | 3.659404e-8 |
GO:0033085 | negative regulation of T cell differentiation in thymus | 4.777145e-8 |
GO:0006693 | prostaglandin metabolic process | 4.781020e-8 |
GO:0034505 | tooth mineralization | 5.046276e-8 |
GO:2000106 | regulation of leukocyte apoptosis | 5.590990e-8 |
GO:0019216 | regulation of lipid metabolic process | 5.932786e-8 |
GO:0071230 | cellular response to amino acid stimulus | 6.485899e-8 |
GO:0070508 | cholesterol import | 6.705885e-8 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 7.050354e-8 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 7.263502e-8 |
GO:0030818 | negative regulation of cAMP biosynthetic process | 7.681002e-8 |
GO:0032963 | collagen metabolic process | 8.089569e-8 |
GO:0014044 | Schwann cell development | 8.124312e-8 |
GO:0046890 | regulation of lipid biosynthetic process | 9.048341e-8 |
GO:0002577 | regulation of antigen processing and presentation | 9.479566e-8 |
GO:0046889 | positive regulation of lipid biosynthetic process | 1.332051e-7 |
GO:0046885 | regulation of hormone biosynthetic process | 1.419196e-7 |
GO:0015844 | monoamine transport | 1.678724e-7 |
GO:0050921 | positive regulation of chemotaxis | 1.742900e-7 |
GO:0006633 | fatty acid biosynthetic process | 1.790716e-7 |
GO:0071229 | cellular response to acid | 1.963043e-7 |
GO:0030595 | leukocyte chemotaxis | 1.963043e-7 |
GO:0034382 | chylomicron remnant clearance | 2.009503e-7 |
GO:0051004 | regulation of lipoprotein lipase activity | 2.480914e-7 |
GO:0045980 | negative regulation of nucleotide metabolic process | 2.692854e-7 |
GO:0046886 | positive regulation of hormone biosynthetic process | 2.697773e-7 |
GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 2.850556e-7 |
GO:0019884 | antigen processing and presentation of exogenous antigen | 3.562043e-7 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 3.821588e-7 |
GO:0050900 | leukocyte migration | 4.391693e-7 |
GO:0033344 | cholesterol efflux | 4.581963e-7 |
GO:0070328 | triglyceride homeostasis | 5.126350e-7 |
GO:0050994 | regulation of lipid catabolic process | 5.646826e-7 |
GO:0010893 | positive regulation of steroid biosynthetic process | 5.825244e-7 |
GO:0031960 | response to corticosteroid stimulus | 6.301919e-7 |
GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 6.714869e-7 |
GO:0010984 | regulation of lipoprotein particle clearance | 6.956739e-7 |
GO:0002250 | adaptive immune response | 6.972823e-7 |
GO:0070206 | protein trimerization | 7.533988e-7 |
GO:0002886 | regulation of myeloid leukocyte mediated immunity | 8.231640e-7 |
GO:0048545 | response to steroid hormone stimulus | 8.508437e-7 |
GO:0016125 | sterol metabolic process | 8.703901e-7 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 8.961309e-7 |
GO:0048771 | tissue remodeling | 9.023254e-7 |
GO:0006695 | cholesterol biosynthetic process | 9.180410e-7 |
GO:0051347 | positive regulation of transferase activity | 1.000027e-6 |
GO:0032103 | positive regulation of response to external stimulus | 1.068310e-6 |
GO:0071874 | cellular response to norepinephrine stimulus | 1.103195e-6 |
GO:0046456 | icosanoid biosynthetic process | 1.266283e-6 |
GO:0006952 | defense response | 1.328883e-6 |
GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter | 1.453385e-6 |
GO:0043691 | reverse cholesterol transport | 1.613646e-6 |
GO:0090030 | regulation of steroid hormone biosynthetic process | 1.704508e-6 |
GO:0090022 | regulation of neutrophil chemotaxis | 1.922597e-6 |
GO:0010243 | response to organic nitrogen | 1.998503e-6 |
GO:0050920 | regulation of chemotaxis | 2.099867e-6 |
GO:0048148 | behavioral response to cocaine | 2.107030e-6 |
GO:0050713 | negative regulation of interleukin-1 beta secretion | 2.184115e-6 |
GO:0014037 | Schwann cell differentiation | 2.453513e-6 |
GO:0002821 | positive regulation of adaptive immune response | 2.483308e-6 |
GO:0060191 | regulation of lipase activity | 2.515973e-6 |
GO:0006636 | unsaturated fatty acid biosynthetic process | 2.616951e-6 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 2.651070e-6 |
GO:0006690 | icosanoid metabolic process | 2.994291e-6 |
GO:0090031 | positive regulation of steroid hormone biosynthetic process | 3.126590e-6 |
GO:0030865 | cortical cytoskeleton organization | 3.148268e-6 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 3.209052e-6 |
GO:0032352 | positive regulation of hormone metabolic process | 3.218372e-6 |
GO:0042304 | regulation of fatty acid biosynthetic process | 3.237273e-6 |
GO:0042415 | norepinephrine metabolic process | 3.268179e-6 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 3.380565e-6 |
GO:0000305 | response to oxygen radical | 3.486448e-6 |
GO:0019430 | removal of superoxide radicals | 3.504280e-6 |
GO:0014075 | response to amine stimulus | 3.548248e-6 |
GO:0002718 | regulation of cytokine production involved in immune response | 3.854152e-6 |
GO:0032964 | collagen biosynthetic process | 3.915407e-6 |
GO:0033081 | regulation of T cell differentiation in thymus | 4.002115e-6 |
GO:0033275 | actin-myosin filament sliding | 4.052700e-6 |
GO:0022011 | myelination in peripheral nervous system | 4.090380e-6 |
GO:0050995 | negative regulation of lipid catabolic process | 4.099619e-6 |
GO:2000108 | positive regulation of leukocyte apoptosis | 4.561853e-6 |
GO:0042149 | cellular response to glucose starvation | 4.652086e-6 |
GO:0006707 | cholesterol catabolic process | 5.072981e-6 |
GO:0033674 | positive regulation of kinase activity | 5.140178e-6 |
GO:0050810 | regulation of steroid biosynthetic process | 5.217455e-6 |
GO:0021782 | glial cell development | 5.218525e-6 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 5.339205e-6 |
GO:0050872 | white fat cell differentiation | 6.018154e-6 |
GO:0002642 | positive regulation of immunoglobulin biosynthetic process | 6.294479e-6 |
GO:0006694 | steroid biosynthetic process | 6.665031e-6 |
GO:0000303 | response to superoxide | 7.308633e-6 |
GO:0033505 | floor plate morphogenesis | 8.183418e-6 |
GO:0043031 | negative regulation of macrophage activation | 8.204654e-6 |
GO:0044243 | multicellular organismal catabolic process | 8.288519e-6 |
GO:0032488 | Cdc42 protein signal transduction | 8.540489e-6 |
GO:0045860 | positive regulation of protein kinase activity | 8.779099e-6 |
GO:0061001 | regulation of dendritic spine morphogenesis | 8.937152e-6 |
GO:0032094 | response to food | 9.094424e-6 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 1.025497e-5 |
GO:0043085 | positive regulation of catalytic activity | 1.054121e-5 |
GO:0006833 | water transport | 1.128313e-5 |
GO:0060343 | trabecula formation | 1.146278e-5 |
GO:0061077 | chaperone-mediated protein folding | 1.215009e-5 |
GO:0072376 | protein activation cascade | 1.268147e-5 |
GO:0015850 | organic alcohol transport | 1.268401e-5 |
GO:0051937 | catecholamine transport | 1.331316e-5 |
GO:0045907 | positive regulation of vasoconstriction | 1.334981e-5 |
GO:0007493 | endodermal cell fate determination | 1.369890e-5 |
GO:0010765 | positive regulation of sodium ion transport | 1.373907e-5 |
GO:0070252 | actin-mediated cell contraction | 1.417481e-5 |
GO:0050865 | regulation of cell activation | 1.435923e-5 |
GO:0044341 | sodium-dependent phosphate transport | 1.441550e-5 |
GO:0090342 | regulation of cell aging | 1.488649e-5 |
GO:0043300 | regulation of leukocyte degranulation | 1.622600e-5 |
GO:0007320 | insemination | 1.686732e-5 |
GO:0001974 | blood vessel remodeling | 1.744403e-5 |
GO:0002251 | organ or tissue specific immune response | 1.746465e-5 |
GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling | 1.802397e-5 |
GO:0007614 | short-term memory | 1.860368e-5 |
GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 1.864325e-5 |
GO:0009628 | response to abiotic stimulus | 1.878455e-5 |
GO:0008203 | cholesterol metabolic process | 1.975306e-5 |
GO:0045581 | negative regulation of T cell differentiation | 2.027664e-5 |
GO:0007522 | visceral muscle development | 2.078473e-5 |
GO:0032369 | negative regulation of lipid transport | 2.161221e-5 |
GO:0002385 | mucosal immune response | 2.172459e-5 |
GO:0002252 | immune effector process | 2.318026e-5 |
GO:0070741 | response to interleukin-6 | 2.381848e-5 |
GO:0002690 | positive regulation of leukocyte chemotaxis | 2.467289e-5 |
GO:0008211 | glucocorticoid metabolic process | 2.523283e-5 |
GO:0045760 | positive regulation of action potential | 2.689188e-5 |
GO:0035307 | positive regulation of protein dephosphorylation | 2.701961e-5 |
GO:0032374 | regulation of cholesterol transport | 2.783580e-5 |
GO:0002694 | regulation of leukocyte activation | 2.821033e-5 |
GO:0050432 | catecholamine secretion | 3.005844e-5 |
GO:0031424 | keratinization | 3.053358e-5 |
GO:0042487 | regulation of odontogenesis of dentine-containing tooth | 3.115074e-5 |
GO:0044240 | multicellular organismal lipid catabolic process | 3.244991e-5 |
GO:0002344 | B cell affinity maturation | 3.333487e-5 |
GO:0001985 | negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure | 3.411262e-5 |
GO:0046394 | carboxylic acid biosynthetic process | 3.490613e-5 |
GO:0006956 | complement activation | 3.684219e-5 |
GO:0035306 | positive regulation of dephosphorylation | 3.811832e-5 |
GO:0030049 | muscle filament sliding | 4.029900e-5 |
GO:0050706 | regulation of interleukin-1 beta secretion | 4.079308e-5 |
GO:0090343 | positive regulation of cell aging | 4.177189e-5 |
GO:0045725 | positive regulation of glycogen biosynthetic process | 4.294859e-5 |
GO:0008340 | determination of adult lifespan | 4.437961e-5 |
GO:0060192 | negative regulation of lipase activity | 4.461806e-5 |
GO:0045087 | innate immune response | 4.587758e-5 |
GO:0009719 | response to endogenous stimulus | 4.868140e-5 |
GO:0030199 | collagen fibril organization | 4.897780e-5 |
GO:0051085 | chaperone mediated protein folding requiring cofactor | 4.974295e-5 |
GO:0002906 | negative regulation of mature B cell apoptosis | 5.304953e-5 |
GO:0016925 | protein sumoylation | 5.586551e-5 |
GO:0048242 | epinephrine secretion | 5.593238e-5 |
GO:0007422 | peripheral nervous system development | 5.600355e-5 |
GO:0032350 | regulation of hormone metabolic process | 5.814618e-5 |
GO:0043200 | response to amino acid stimulus | 5.817345e-5 |
GO:0032375 | negative regulation of cholesterol transport | 6.051230e-5 |
GO:0002864 | regulation of acute inflammatory response to antigenic stimulus | 6.051230e-5 |
GO:0046847 | filopodium assembly | 6.212925e-5 |
GO:0015724 | formate transport | 6.313509e-5 |
GO:0002442 | serotonin secretion involved in inflammatory response | 6.320079e-5 |
GO:0006378 | mRNA polyadenylation | 6.431067e-5 |
GO:0002673 | regulation of acute inflammatory response | 6.504378e-5 |
GO:0048739 | cardiac muscle fiber development | 6.538569e-5 |
GO:0010741 | negative regulation of intracellular protein kinase cascade | 6.565759e-5 |
GO:0043535 | regulation of blood vessel endothelial cell migration | 6.633373e-5 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 6.839721e-5 |
GO:0035249 | synaptic transmission, glutamatergic | 6.928053e-5 |
GO:0006954 | inflammatory response | 6.983733e-5 |
GO:0050711 | negative regulation of interleukin-1 secretion | 7.231952e-5 |
GO:0042104 | positive regulation of activated T cell proliferation | 7.595210e-5 |
GO:0019217 | regulation of fatty acid metabolic process | 7.660814e-5 |
GO:0001935 | endothelial cell proliferation | 8.338305e-5 |
GO:0010906 | regulation of glucose metabolic process | 8.358078e-5 |
GO:0010565 | regulation of cellular ketone metabolic process | 8.364762e-5 |
GO:0002688 | regulation of leukocyte chemotaxis | 8.384015e-5 |
GO:0006958 | complement activation, classical pathway | 8.427515e-5 |
GO:0033003 | regulation of mast cell activation | 8.520214e-5 |
GO:2000772 | regulation of cellular senescence | 8.560522e-5 |
GO:0002604 | regulation of dendritic cell antigen processing and presentation | 9.045849e-5 |
GO:0030035 | microspike assembly | 9.196900e-5 |
GO:0050790 | regulation of catalytic activity | 9.366737e-5 |
GO:0045937 | positive regulation of phosphate metabolic process | 9.499492e-5 |
GO:0008610 | lipid biosynthetic process | 9.874702e-5 |
GO:0051338 | regulation of transferase activity | 1.024037e-4 |
GO:0070875 | positive regulation of glycogen metabolic process | 1.029566e-4 |
GO:0043503 | skeletal muscle fiber adaptation | 1.037412e-4 |
GO:0001826 | inner cell mass cell differentiation | 1.037412e-4 |
GO:0007512 | adult heart development | 1.076770e-4 |
GO:0048644 | muscle organ morphogenesis | 1.095079e-4 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 1.102891e-4 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 1.105142e-4 |
GO:0044093 | positive regulation of molecular function | 1.108031e-4 |
GO:0031440 | regulation of mRNA 3'-end processing | 1.108119e-4 |
GO:0045922 | negative regulation of fatty acid metabolic process | 1.157646e-4 |
GO:0017157 | regulation of exocytosis | 1.184118e-4 |
GO:0043549 | regulation of kinase activity | 1.196899e-4 |
GO:0071495 | cellular response to endogenous stimulus | 1.222780e-4 |
GO:0042044 | fluid transport | 1.250668e-4 |
GO:0014738 | regulation of muscle hyperplasia | 1.259470e-4 |
GO:0005979 | regulation of glycogen biosynthetic process | 1.266474e-4 |
GO:0045859 | regulation of protein kinase activity | 1.275695e-4 |
GO:0002697 | regulation of immune effector process | 1.311077e-4 |
GO:0045620 | negative regulation of lymphocyte differentiation | 1.328718e-4 |
GO:0007418 | ventral midline development | 1.377456e-4 |
GO:0002115 | store-operated calcium entry | 1.394758e-4 |
GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 1.402627e-4 |
GO:0060696 | regulation of phospholipid catabolic process | 1.402946e-4 |
GO:0001817 | regulation of cytokine production | 1.461381e-4 |
GO:0002883 | regulation of hypersensitivity | 1.491547e-4 |
GO:0018149 | peptide cross-linking | 1.495998e-4 |
GO:0006547 | histidine metabolic process | 1.544757e-4 |
GO:0030301 | cholesterol transport | 1.557485e-4 |
GO:0002827 | positive regulation of T-helper 1 type immune response | 1.579389e-4 |
GO:0043067 | regulation of programmed cell death | 1.588470e-4 |
GO:0002554 | serotonin secretion by platelet | 1.635255e-4 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 1.657584e-4 |
GO:0050863 | regulation of T cell activation | 1.671871e-4 |
GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response | 1.693944e-4 |
GO:0034369 | plasma lipoprotein particle remodeling | 1.704348e-4 |
GO:0051345 | positive regulation of hydrolase activity | 1.761282e-4 |
GO:0044255 | cellular lipid metabolic process | 1.763709e-4 |
GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 1.767126e-4 |
GO:0050778 | positive regulation of immune response | 1.786524e-4 |
GO:0050704 | regulation of interleukin-1 secretion | 1.807757e-4 |
GO:0043467 | regulation of generation of precursor metabolites and energy | 1.825744e-4 |
GO:0006066 | alcohol metabolic process | 1.828730e-4 |
GO:0060299 | negative regulation of sarcomere organization | 1.848997e-4 |
GO:0060307 | regulation of ventricular cardiomyocyte membrane repolarization | 1.848997e-4 |
GO:0042703 | menstruation | 1.848997e-4 |
GO:0019101 | female somatic sex determination | 1.848997e-4 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 1.896075e-4 |
GO:0006669 | sphinganine-1-phosphate biosynthetic process | 1.943694e-4 |
GO:0002687 | positive regulation of leukocyte migration | 1.973257e-4 |
GO:0043462 | regulation of ATPase activity | 1.990002e-4 |
GO:0006826 | iron ion transport | 2.003028e-4 |
GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter | 2.038550e-4 |
GO:0009991 | response to extracellular stimulus | 2.050978e-4 |
GO:0051384 | response to glucocorticoid stimulus | 2.087131e-4 |
GO:0002739 | regulation of cytokine secretion involved in immune response | 2.095091e-4 |
GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 2.221750e-4 |
GO:0070873 | regulation of glycogen metabolic process | 2.252104e-4 |
GO:0055088 | lipid homeostasis | 2.264130e-4 |
GO:0033136 | serine phosphorylation of STAT3 protein | 2.274065e-4 |
GO:0021508 | floor plate formation | 2.274065e-4 |
GO:0042981 | regulation of apoptosis | 2.286831e-4 |
GO:0061383 | trabecula morphogenesis | 2.315539e-4 |
GO:0015914 | phospholipid transport | 2.382047e-4 |
GO:0071827 | plasma lipoprotein particle organization | 2.449742e-4 |
GO:0048935 | peripheral nervous system neuron development | 2.486578e-4 |
GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 2.492810e-4 |
GO:0033504 | floor plate development | 2.562703e-4 |
GO:0050776 | regulation of immune response | 2.631873e-4 |
GO:0002440 | production of molecular mediator of immune response | 2.667571e-4 |
GO:0006706 | steroid catabolic process | 2.710909e-4 |
GO:0002576 | platelet degranulation | 2.713769e-4 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 2.750965e-4 |
GO:0010897 | negative regulation of triglyceride catabolic process | 2.750965e-4 |
GO:0015684 | ferrous iron transport | 2.804267e-4 |
GO:0010288 | response to lead ion | 2.825321e-4 |
GO:0002903 | negative regulation of B cell apoptosis | 2.825321e-4 |
GO:0006548 | histidine catabolic process | 2.899779e-4 |
GO:0032516 | positive regulation of phosphoprotein phosphatase activity | 2.901070e-4 |
GO:0002027 | regulation of heart rate | 2.919927e-4 |
GO:0002885 | positive regulation of hypersensitivity | 2.929098e-4 |
GO:0045723 | positive regulation of fatty acid biosynthetic process | 2.944116e-4 |
GO:0051084 | 'de novo' posttranslational protein folding | 2.945583e-4 |
GO:0006629 | lipid metabolic process | 3.087388e-4 |
GO:0010896 | regulation of triglyceride catabolic process | 3.091037e-4 |
GO:0070887 | cellular response to chemical stimulus | 3.093130e-4 |
GO:0071732 | cellular response to nitric oxide | 3.136907e-4 |
GO:0009725 | response to hormone stimulus | 3.226463e-4 |
GO:0046006 | regulation of activated T cell proliferation | 3.231779e-4 |
GO:0060627 | regulation of vesicle-mediated transport | 3.232210e-4 |
GO:0006941 | striated muscle contraction | 3.232580e-4 |
GO:0001932 | regulation of protein phosphorylation | 3.331919e-4 |
GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator | 3.339811e-4 |
GO:0019220 | regulation of phosphate metabolic process | 3.428358e-4 |
GO:0042632 | cholesterol homeostasis | 3.496457e-4 |
GO:0002700 | regulation of production of molecular mediator of immune response | 3.540998e-4 |
GO:0051291 | protein heterooligomerization | 3.595334e-4 |
GO:0015837 | amine transport | 3.632302e-4 |
GO:0050651 | dermatan sulfate proteoglycan biosynthetic process | 3.686873e-4 |
GO:0009103 | lipopolysaccharide biosynthetic process | 3.720282e-4 |
GO:0048241 | epinephrine transport | 3.955505e-4 |
GO:0033131 | regulation of glucokinase activity | 3.975684e-4 |
GO:0051591 | response to cAMP | 4.019198e-4 |
GO:0031016 | pancreas development | 4.127616e-4 |
GO:0030300 | regulation of intestinal cholesterol absorption | 4.185555e-4 |
GO:0010907 | positive regulation of glucose metabolic process | 4.198303e-4 |
GO:0045740 | positive regulation of DNA replication | 4.226363e-4 |
GO:0071731 | response to nitric oxide | 4.311375e-4 |
GO:0042137 | sequestering of neurotransmitter | 4.373335e-4 |
GO:0042661 | regulation of mesodermal cell fate specification | 4.411715e-4 |
GO:0001101 | response to acid | 4.437437e-4 |
GO:0090201 | negative regulation of release of cytochrome c from mitochondria | 4.462252e-4 |
GO:0042325 | regulation of phosphorylation | 4.776740e-4 |
GO:0030240 | skeletal muscle thin filament assembly | 4.824856e-4 |
GO:0030866 | cortical actin cytoskeleton organization | 4.891904e-4 |
GO:0000105 | histidine biosynthetic process | 5.053492e-4 |
GO:0010936 | negative regulation of macrophage cytokine production | 5.132775e-4 |
GO:0002026 | regulation of the force of heart contraction | 5.271399e-4 |
GO:0032733 | positive regulation of interleukin-10 production | 5.295234e-4 |
GO:0016310 | phosphorylation | 5.589741e-4 |
GO:0046069 | cGMP catabolic process | 5.594763e-4 |
GO:0065009 | regulation of molecular function | 5.662329e-4 |
GO:0002866 | positive regulation of acute inflammatory response to antigenic stimulus | 5.681561e-4 |
GO:0050795 | regulation of behavior | 5.940435e-4 |
GO:0006109 | regulation of carbohydrate metabolic process | 6.058080e-4 |
GO:0032287 | peripheral nervous system myelin maintenance | 6.149451e-4 |
GO:0031399 | regulation of protein modification process | 6.172115e-4 |
GO:0009134 | nucleoside diphosphate catabolic process | 6.212721e-4 |
GO:0008366 | axon ensheathment | 6.216517e-4 |
GO:0002377 | immunoglobulin production | 6.406455e-4 |
GO:0032912 | negative regulation of transforming growth factor beta2 production | 6.698679e-4 |
GO:0034435 | cholesterol esterification | 6.965038e-4 |
GO:0040017 | positive regulation of locomotion | 7.280910e-4 |
GO:0034380 | high-density lipoprotein particle assembly | 7.345886e-4 |
GO:0050685 | positive regulation of mRNA processing | 7.573664e-4 |
GO:0070665 | positive regulation of leukocyte proliferation | 7.620792e-4 |
GO:0016338 | calcium-independent cell-cell adhesion | 7.766561e-4 |
GO:0032878 | regulation of establishment or maintenance of cell polarity | 7.809442e-4 |
GO:0002407 | dendritic cell chemotaxis | 7.876490e-4 |
GO:0022010 | central nervous system myelination | 7.881147e-4 |
GO:0071702 | organic substance transport | 7.886421e-4 |
GO:0021936 | regulation of cerebellar granule cell precursor proliferation | 7.994723e-4 |
GO:0007009 | plasma membrane organization | 8.006938e-4 |
GO:0055072 | iron ion homeostasis | 8.141989e-4 |
GO:0097035 | regulation of membrane lipid distribution | 8.157757e-4 |
GO:0014049 | positive regulation of glutamate secretion | 8.256757e-4 |
GO:0010675 | regulation of cellular carbohydrate metabolic process | 8.382831e-4 |
GO:0043084 | penile erection | 8.492896e-4 |
GO:0042501 | serine phosphorylation of STAT protein | 8.492896e-4 |
GO:0010812 | negative regulation of cell-substrate adhesion | 8.505219e-4 |
GO:0051272 | positive regulation of cellular component movement | 8.678040e-4 |
GO:0015749 | monosaccharide transport | 8.925689e-4 |
GO:0021819 | layer formation in cerebral cortex | 8.947420e-4 |
GO:2000107 | negative regulation of leukocyte apoptosis | 9.010299e-4 |
GO:0042327 | positive regulation of phosphorylation | 9.013107e-4 |
GO:0050871 | positive regulation of B cell activation | 9.034465e-4 |
GO:0071622 | regulation of granulocyte chemotaxis | 9.068707e-4 |
GO:0010614 | negative regulation of cardiac muscle hypertrophy | 9.077003e-4 |
GO:0006760 | folic acid-containing compound metabolic process | 9.102553e-4 |
GO:0070305 | response to cGMP | 9.114654e-4 |
GO:0035264 | multicellular organism growth | 9.344540e-4 |
GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway | 9.589911e-4 |
GO:0060326 | cell chemotaxis | 9.648011e-4 |
GO:0042552 | myelination | 9.666680e-4 |
GO:0001934 | positive regulation of protein phosphorylation | 9.694045e-4 |
GO:0051182 | coenzyme transport | 9.727091e-4 |
GO:2000178 | negative regulation of neural precursor cell proliferation | 9.828588e-4 |
GO:0006796 | phosphate-containing compound metabolic process | 9.828768e-4 |
GO:0006360 | transcription from RNA polymerase I promoter | 9.859234e-4 |
GO:0032368 | regulation of lipid transport | 9.973567e-4 |
GO:0043304 | regulation of mast cell degranulation | 9.978218e-4 |
GO:0032946 | positive regulation of mononuclear cell proliferation | 1.007072e-3 |
GO:0060415 | muscle tissue morphogenesis | 1.007168e-3 |
GO:0015791 | polyol transport | 1.009494e-3 |
GO:0001819 | positive regulation of cytokine production | 1.012737e-3 |
GO:0000492 | box C/D snoRNP assembly | 1.013972e-3 |
GO:0032530 | regulation of microvillus organization | 1.031028e-3 |
GO:0002074 | extraocular skeletal muscle development | 1.031028e-3 |
GO:0006487 | protein N-linked glycosylation | 1.054467e-3 |
GO:0043405 | regulation of MAP kinase activity | 1.064580e-3 |
GO:0002830 | positive regulation of type 2 immune response | 1.076614e-3 |
GO:0001820 | serotonin secretion | 1.076614e-3 |
GO:0031427 | response to methotrexate | 1.083767e-3 |
GO:0043217 | myelin maintenance | 1.104417e-3 |
GO:0002685 | regulation of leukocyte migration | 1.104498e-3 |
GO:0030239 | myofibril assembly | 1.110463e-3 |
GO:0002824 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.116001e-3 |
GO:0060620 | regulation of cholesterol import | 1.122081e-3 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 1.124243e-3 |
GO:0030593 | neutrophil chemotaxis | 1.126779e-3 |
GO:0072539 | T-helper 17 cell differentiation | 1.153882e-3 |
GO:0006545 | glycine biosynthetic process | 1.153882e-3 |
GO:0015876 | acetyl-CoA transport | 1.159017e-3 |
GO:0031579 | membrane raft organization | 1.161948e-3 |
GO:0010823 | negative regulation of mitochondrion organization | 1.161948e-3 |
GO:0043525 | positive regulation of neuron apoptosis | 1.164030e-3 |
GO:0071705 | nitrogen compound transport | 1.167967e-3 |
GO:0071593 | lymphocyte aggregation | 1.168725e-3 |
GO:0006668 | sphinganine-1-phosphate metabolic process | 1.168725e-3 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 1.189130e-3 |
GO:0060426 | lung vasculature development | 1.190505e-3 |
GO:0051249 | regulation of lymphocyte activation | 1.199899e-3 |
GO:0007586 | digestion | 1.200089e-3 |
GO:2001021 | negative regulation of response to DNA damage stimulus | 1.225558e-3 |
GO:0030826 | regulation of cGMP biosynthetic process | 1.235910e-3 |
GO:0035304 | regulation of protein dephosphorylation | 1.237832e-3 |
GO:0051270 | regulation of cellular component movement | 1.239858e-3 |
GO:0042711 | maternal behavior | 1.246430e-3 |
GO:0045103 | intermediate filament-based process | 1.285278e-3 |
GO:0050710 | negative regulation of cytokine secretion | 1.285641e-3 |
GO:0002861 | regulation of inflammatory response to antigenic stimulus | 1.288881e-3 |
GO:0015920 | lipopolysaccharide transport | 1.302113e-3 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 1.302113e-3 |
GO:0045840 | positive regulation of mitosis | 1.314085e-3 |
GO:0007517 | muscle organ development | 1.332689e-3 |
GO:0006631 | fatty acid metabolic process | 1.348242e-3 |
GO:0044283 | small molecule biosynthetic process | 1.350269e-3 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 1.361781e-3 |
GO:0031032 | actomyosin structure organization | 1.375535e-3 |
GO:0060621 | negative regulation of cholesterol import | 1.383543e-3 |
GO:0060052 | neurofilament cytoskeleton organization | 1.389008e-3 |
GO:0031295 | T cell costimulation | 1.389699e-3 |
GO:0010259 | multicellular organismal aging | 1.405418e-3 |
GO:0071299 | cellular response to vitamin A | 1.424070e-3 |
GO:0009416 | response to light stimulus | 1.434073e-3 |
GO:0002684 | positive regulation of immune system process | 1.463680e-3 |
GO:0006959 | humoral immune response | 1.499442e-3 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 1.500245e-3 |
GO:0042136 | neurotransmitter biosynthetic process | 1.500245e-3 |
GO:0002426 | immunoglobulin production in mucosal tissue | 1.500245e-3 |
GO:0006879 | cellular iron ion homeostasis | 1.509726e-3 |
GO:0002376 | immune system process | 1.512771e-3 |
GO:0009100 | glycoprotein metabolic process | 1.533004e-3 |
GO:0071385 | cellular response to glucocorticoid stimulus | 1.535067e-3 |
GO:0007618 | mating | 1.545733e-3 |
GO:0043270 | positive regulation of ion transport | 1.562210e-3 |
GO:0048261 | negative regulation of receptor-mediated endocytosis | 1.570720e-3 |
GO:0046604 | positive regulation of mitotic centrosome separation | 1.585789e-3 |
GO:0043252 | sodium-independent organic anion transport | 1.585789e-3 |
GO:0002561 | basophil degranulation | 1.585789e-3 |
GO:0032532 | regulation of microvillus length | 1.585789e-3 |
GO:0031124 | mRNA 3'-end processing | 1.596613e-3 |
GO:0003229 | ventricular cardiac muscle tissue development | 1.631145e-3 |
GO:0007602 | phototransduction | 1.646771e-3 |
GO:2000189 | positive regulation of cholesterol homeostasis | 1.669470e-3 |
GO:0050861 | positive regulation of B cell receptor signaling pathway | 1.669470e-3 |
GO:0048320 | axial mesoderm formation | 1.669470e-3 |
GO:0050671 | positive regulation of lymphocyte proliferation | 1.671250e-3 |
GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 1.674968e-3 |
GO:0046655 | folic acid metabolic process | 1.679527e-3 |
GO:0008016 | regulation of heart contraction | 1.699944e-3 |
GO:0051336 | regulation of hydrolase activity | 1.717496e-3 |
GO:0035094 | response to nicotine | 1.719516e-3 |
GO:0048520 | positive regulation of behavior | 1.728041e-3 |
GO:0001993 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine | 1.734682e-3 |
GO:0010935 | regulation of macrophage cytokine production | 1.734682e-3 |
GO:0045924 | regulation of female receptivity | 1.746501e-3 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 1.794052e-3 |
GO:0003044 | regulation of systemic arterial blood pressure mediated by a chemical signal | 1.794052e-3 |
GO:0043589 | skin morphogenesis | 1.810700e-3 |
GO:0006641 | triglyceride metabolic process | 1.812845e-3 |
GO:0008645 | hexose transport | 1.814278e-3 |
GO:2000147 | positive regulation of cell motility | 1.824085e-3 |
GO:2000273 | positive regulation of receptor activity | 1.843714e-3 |
GO:0010976 | positive regulation of neuron projection development | 1.866851e-3 |
GO:0010941 | regulation of cell death | 1.871033e-3 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 1.902771e-3 |
GO:0071383 | cellular response to steroid hormone stimulus | 1.919016e-3 |
GO:0071453 | cellular response to oxygen levels | 1.943281e-3 |
GO:2000412 | positive regulation of thymocyte migration | 1.947963e-3 |
GO:0031998 | regulation of fatty acid beta-oxidation | 1.954401e-3 |
GO:0014051 | gamma-aminobutyric acid secretion | 1.960486e-3 |
GO:0010460 | positive regulation of heart rate | 1.983240e-3 |
GO:0006013 | mannose metabolic process | 1.999132e-3 |
GO:0071300 | cellular response to retinoic acid | 2.030868e-3 |
GO:0002125 | maternal aggressive behavior | 2.032280e-3 |
GO:0060709 | glycogen cell development involved in embryonic placenta development | 2.032280e-3 |
GO:0072011 | glomerular endothelium development | 2.032280e-3 |
GO:0018993 | somatic sex determination | 2.032280e-3 |
GO:0031214 | biomineral tissue development | 2.050324e-3 |
GO:0043502 | regulation of muscle adaptation | 2.054010e-3 |
GO:0006555 | methionine metabolic process | 2.077714e-3 |